135 related articles for article (PubMed ID: 25577268)
1. Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry.
Schwacke J; Millar TP; Hammond CE; Saha A; Hoffman BJ; Romagnuolo J; Hill EG; Smolka AJ
Dig Dis Sci; 2015 Jun; 60(6):1645-54. PubMed ID: 25577268
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
4. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Periyasamy A; Gopisetty G; Veluswami S; Joyimallaya Subramanium M; Thangarajan R
Biomarkers; 2015; 20(5):292-8. PubMed ID: 26329525
[TBL] [Abstract][Full Text] [Related]
6. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
[TBL] [Abstract][Full Text] [Related]
7. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Protocol in Esophageal Adenocarcinoma.
Kelly P
Methods Mol Biol; 2018; 1756():281-293. PubMed ID: 29600378
[TBL] [Abstract][Full Text] [Related]
9. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
11. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
Wan QL; Hou XS; Zhao G
Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
[TBL] [Abstract][Full Text] [Related]
12. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
[TBL] [Abstract][Full Text] [Related]
13. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
14. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
Fan NJ; Gao CF; Wang XL
OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
[TBL] [Abstract][Full Text] [Related]
15. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
Kelly P; Paulin F; Lamont D; Baker L; Clearly S; Exon D; Thompson A
Br J Cancer; 2012 Feb; 106(5):955-61. PubMed ID: 22294182
[TBL] [Abstract][Full Text] [Related]
17. New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Guo R; Pan C; Shen J; Liu C
J Cancer Res Clin Oncol; 2011 Mar; 137(3):513-9. PubMed ID: 20490864
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
20. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
